A compound ointment for diabetic wound healing and preparation method thereof

Compound ointment combining SOD cationic micelles, Ba33112 anion micelles and collagen hydrolysate liposomes has solved the problem of difficulty in healing in diabetic wounds, achieved stable HIF-1α activity and antibacterial effects in a hypoxic environment, significantly accelerating the wound heal.

CN116159019BActive Publication Date: 2024-11-22NANTONG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310227473.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-03-10
Publication Date
2024-11-22
Estimated Expiration
2043-03-10

AI Technical Summary

Technical Problem

Diabetic wounds are difficult to heal due to hypoxia and inflammation, and the prior art is difficult to effectively improve the ischemia-hypoxia environment and inhibit oxidative stress, and lack dressings with broad-spectrum antibacterial effects.

Method used

Compound ointment that combines SOD cationic micelles and Ba33112 anion micelles with collagen hydrolysate liposomes isolates the components by pelletizing carriers, adsorbing Fe(II) and ROS, stabilizes HIF-1α activity, promotes neovascularization, and passes The antibacterial effects of SOD and Ba33112 accelerate healing.

Benefits of technology

Stabilize HIF-1α activity in hypoxia and hyperglycemia, promote neovascularization, relieve symptoms of hypoxia, have bactericidal and disinfection effects, significantly accelerate diabetic wound healing, and control lipid peroxidation and ferrous death.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116159019B_ABST
    Figure CN116159019B_ABST
Patent Text Reader

Abstract

The invention belongs to the field of drug combination and preparation, and discloses a compound ointment for diabetic wound healing and a preparation method thereof, wherein the compound ointment is compounded by superoxide dismutase (SOD) cationic micelles, deferoxamine mesylate (Ba33112) anionic micelles and collagen hydrolyzate liposomes. The compound ointment prepared by the preparation method of the invention has the characteristics of accelerating diabetic wound healing and resisting infection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of drug combinations and preparations, and particularly relates to a compound ointment for healing diabetic wounds and a preparation method thereof. Background Art

[0002] The 2022 national epidemiological survey showed that the total number of people with diabetes was 129.8 million, the prevalence of diabetes was 12.8%, the prevalence of prediabetes was 35.2%, and about 5%-10% of prediabetes patients progressed to diabetes each year. During the onset of diabetes, 30% of patients will develop skin infections. Skin lesions are often a precursor to diabetes, and they often recur and linger. For people with diabetes, once a skin infection occurs, the symptoms of diabetes can worsen and are particularly difficult to control. When the condition of diabetes worsens, especially when ketoacidosis occurs, the infection can further worsen, and the two often form a vicious cycle.

[0003] A certain level of hypoxia at the wound surface can promote wound healing. For example, the appropriate expression of HIF-1 induced by hypoxia can help promote wound healing. During the inflammatory phase of the wound, HIF-1 promotes the recruitment and differentiation of macrophages. During the proliferation phase of the wound, HIF-1 promotes the growth of blood vessels to the hypoxic area of ​​the wound surface by activating the transcription of multiple angiogenic factors such as VEGF and Ang2, increasing the recruitment and migration of bone marrow progenitor cells at the wound surface, and further promoting the formation of new blood vessels and wound healing. However, when the wound surface is in the inflammatory phase, long-term excessive hypoxia will affect the function of neutrophils and macrophages. A large number of studies have shown that infection is negatively correlated with wound oxygenation, which may be due to the high oxygen-dependent activity of antibacterial enzymes such as myeloperoxidase in neutrophils, which greatly reduces the antibacterial ability of the wound surface under hypoxia, and hypoxia in the wound bed helps bacterial colonization. If the wound surface is supplied with oxygen through hyperbaric oxygen or local oxygen therapy to increase the oxygen partial pressure at the chronic wound surface, the high expression of HIF-1 induced by hypoxia and its regulated pro-angiogenesis effect may be cancelled. In addition, during the coagulation process of diabetic wounds, platelets and serum condense into blood scabs, and red blood cells rupture, releasing SOD and hemoglobin. SOD can use ROS and gaseous oxygen to produce H2O2, and hemoglobin degradation to release Fe(II), which undergoes a Fenton reaction to produce more ROS, which may trigger lipid peroxidation of fibroblasts and immune cells, followed by ferroptosis. Oxygen is a product of SOD and a substrate of the Fenton reaction. Continuous high-concentration supply of oxygen can aggravate this process, making it difficult for the wound to heal, and there is a dilemma in treatment. Therefore, it is urgent to consider the systemic causes of diabetic wounds and prepare a new dressing that can improve the ischemic and hypoxic environment of the wound, inhibit oxidative stress and inflammation, tissue lipid peroxidation and ferroptosis, and have a broad spectrum of antibacterial properties. Summary of the invention

[0004] In view of this, the object of the present invention is to provide a compound ointment for diabetic wound healing and a preparation method thereof, wherein the compound ointment has the effects of accelerating diabetic wound healing and resisting infection.

[0005] In order to solve the above technical problems, the technical solutions provided by the present invention are as follows:

[0006] A method for preparing a compound ointment for diabetic wound healing comprises the following steps:

[0007] S1: Preparation of SOD cationic micelles: dissolve the quaternary ammonium polymer surfactant and SOD in water, stir thoroughly, dialyze, and freeze-dry the retentate to obtain SOD cationic micelles; wherein the dosage ratio of the quaternary ammonium polymer surfactant, SOD, and water is (150-230) mg: (15-23) mg: (15-22) mL;

[0008] S2: Preparation of Ba33112 anionic micelles: sulfonate polymer surfactant and Ba33112 were added to water, stirred thoroughly, dialyzed, and the retentate was freeze-dried to obtain Ba33112 anionic micelles; wherein the amount ratio of sulfonate polymer surfactant, Ba33112 and water was (39-50) mg: (5-18) mg: (4-5) mL;

[0009] S3: Preparation of collagen hydrolyzate liposomes: egg yolk lecithin and cholesterol are dissolved in chloroform, and then the organic reagent is removed by rotary evaporation. After a uniform lipid film is formed on the bottom and inner wall of the ground glass tube, the hydrolyzed collagen solution is added and vortexed to hydrate, and then extruded by a liposome extruder and freeze-dried to obtain collagen hydrolyzate liposomes; wherein the amount ratio of egg yolk lecithin, cholesterol and hydrolyzed collagen solution is (100-120) mg:(20-25) mg:(20-25) mL;

[0010] S4: The SOD cationic micelles, Ba33112 anionic micelles, collagen hydrolyzate liposomes and the ointment are mixed to obtain a compound ointment for diabetic wound healing.

[0011] Preferably, in step S1, the quaternary ammonium polymer surfactant is one of polyquaternium-37, polyquaternium-22 or polyquaternium-11.

[0012] Preferably, in step S1, the weight average molecular weight of the quaternary ammonium salt polymer surfactant is 5000-8400, and the specific activity of SOD is 10000-12000 U / g.

[0013] Preferably, in step S2, the sulfonate polymer surfactant is one of sodium lignin sulfonate or sodium polystyrene sulfonate.

[0014] Preferably, in step S2, the weight average molecular weight of the sulfonate polymer surfactant is 50,000-80,000.

[0015] Preferably, in steps S1 and S2, the dialysis molecular weight cut-off is 10000-14000Da.

[0016] Preferably, in step S3, the concentration of the hydrolyzed collagen solution is 5-12 g / L, the hydration temperature is 55-60° C., and the pore size of the extrusion membrane is 200-400 nm.

[0017] Preferably, in step S4, the dosage ratio of SOD cationic micelles, Ba33112 anionic micelles, collagen hydrolyzate liposomes and ointment is: (0.2-0.8) g: (0.3-0.8) g: (0.5-1.0) g: 100 g.

[0018] The present invention also provides a compound ointment for diabetic wound healing prepared by the preparation method.

[0019] Beneficial effects:

[0020] 1) Ba33112 and SOD are isolated from each other through a granular carrier, and the Ba33112 encapsulated in anionic micelles adsorbs Fe(II) and then chelates it, inhibiting excessive ROS, lipid peroxidation and ferroptosis, stabilizing the expression of HIF-1α and improving the activity of HIF-1α under hypoxia and hyperglycemia, and promoting the formation of downstream new blood vessels. SOD is encapsulated in cationic micelles and adsorbed on the cell membrane. At the same time, it catalyzes the production of O2 and H2O2 by adsorbing ROS in the tissue fluid. The former can relieve the symptoms of hypoxia on the wound surface, and the latter can play a role in sterilization and anti-infection. Moreover, positively charged Fe(II) will not enter the cationic micelles, and superoxide anion radicals will not enter the anionic micelles, preventing the failure of SOD and Ba33112.

[0021] 2) Liposome encapsulation of hydrolyzed collagen can facilitate its internalization by fibroblasts, which is beneficial to collagen deposition on the wound surface and rapid healing. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 This is the curve of the change of wound area rate in the infection wound healing experiment of diabetic rats;

[0023] Figure 2 The MDA content and relative expression of HIF-1α protein in tissues of diabetic rats treated with ointment for 4 days in the infected wound healing experiment. DETAILED DESCRIPTION

[0024] In order to further understand the present invention, preferred embodiments of the present invention are described below in conjunction with examples, but it should be understood that these descriptions are only for further illustrating the features and advantages of the present invention, rather than limiting the claims of the present invention.

[0025] Example 1

[0026] A compound ointment for diabetic wound healing and a preparation method thereof, comprising the following steps:

[0027] 1. Preparation of SOD cationic micelles: 195 mg of polyquaternium-22 with a weight average molecular weight of 6500 and 20 mg of SOD with a specific activity of 11360 U / g were dissolved in 18 ml of water, stirred thoroughly, dialyzed with a molecular weight cutoff of 12500 Da, and the retentate was freeze-dried to obtain SOD cationic micelles;

[0028] 2. Preparation of Ba33112 anionic micelles: 43 mg of sodium lignin sulfonate with a weight average molecular weight of 70,000 and 14 mg of Ba33112 were added to 4.7 ml of water, stirred thoroughly, dialyzed at a molecular weight cutoff of 13,000 Da, and the retentate was freeze-dried to obtain Ba33112 anionic micelles;

[0029] 3. Preparation of collagen hydrolyzate liposomes: 112 mg of egg yolk lecithin and 23 mg of cholesterol were dissolved in chloroform, and then the organic reagent was removed by rotary evaporation. After a uniform lipid film was formed on the bottom and inner wall of the ground glass tube, 22 ml of 9.8 g / L hydrolyzed collagen solution was added and vortexed at 56 ° C for hydration, and then extruded using a liposome extruder with a pore size of 270 nm, and freeze-dried to obtain collagen hydrolyzate liposomes;

[0030] 4. Mix 0.6 g SOD cationic micelles, 0.5 g Ba33112 anionic micelles, 0.9 g collagen hydrolyzate liposomes and 100 g ointment to obtain a compound ointment for diabetic wound healing.

[0031] Example 2

[0032] A compound ointment for diabetic wound healing and a preparation method thereof, comprising the following steps:

[0033] 1. Preparation of SOD cationic micelles: 150 mg of polyquaternium-37 with a weight average molecular weight of 8400 and 23 mg of SOD with a specific activity of 10000U / g were dissolved in 15 ml of water, stirred thoroughly, dialyzed with a molecular weight cutoff of 10000Da, and the retentate was freeze-dried to obtain SOD cationic micelles;

[0034] 2. Preparation of Ba33112 anionic micelles: 39 mg of sodium polystyrene sulfonate with a weight average molecular weight of 80,000 and 5 mg of Ba33112 were added to 4 ml of water, stirred thoroughly, dialyzed at a molecular weight cutoff of 14,000 Da, and the retentate was freeze-dried to obtain Ba33112 anionic micelles;

[0035] 3. Preparation of collagen hydrolyzate liposomes: 100 mg of egg yolk lecithin and 20 mg of cholesterol were dissolved in chloroform, and then the organic reagent was removed by rotary evaporation. After a uniform lipid film was formed on the bottom and inner wall of the ground glass tube, 20 ml of 12 g / L hydrolyzed collagen solution was added and vortexed at 55 ° C for hydration, and then extruded using a liposome extruder with a pore size of 200 nm, and freeze-dried to obtain collagen hydrolyzate liposomes;

[0036] 4. Mix 0.2g SOD cationic micelles, 0.8g Ba33112 anionic micelles, 1.0g collagen hydrolyzate liposomes and 100g ointment to obtain a compound ointment for diabetic wound healing.

[0037] Example 3

[0038] A compound ointment for diabetic wound healing and a preparation method thereof, comprising the following steps:

[0039] 1. Preparation of SOD cationic micelles: 230 mg of polyquaternium-11 with a weight average molecular weight of 5000 and 15 mg of SOD with a specific activity of 12000 U / g were dissolved in 22 ml of water, stirred thoroughly, dialyzed with a molecular weight cutoff of 14000 Da, and the retentate was freeze-dried to obtain SOD cationic micelles;

[0040] 2. Preparation of Ba33112 anionic micelles: 50 mg of sodium lignin sulfonate with a weight average molecular weight of 50,000 and 18 mg of Ba33112 were added to 5 ml of water, stirred thoroughly, dialyzed with a molecular weight cutoff of 10,000 Da, and the retentate was freeze-dried to obtain Ba33112 anionic micelles;

[0041] 3. Preparation of collagen hydrolyzate liposomes: 120 mg of egg yolk lecithin and 25 mg of cholesterol were dissolved in chloroform, and then the organic reagent was removed by rotary evaporation. After a uniform lipid film was formed on the bottom and inner wall of the ground glass tube, 25 ml of 5 g / L hydrolyzed collagen solution was added and vortexed at 60°C for hydration, and then extruded using a liposome extruder with a pore size of 400 nm, and freeze-dried to obtain collagen hydrolyzate liposomes;

[0042] 4. Mix 0.8 g SOD cationic micelles, 0.3 g Ba33112 anionic micelles, 0.5 g collagen hydrolyzate liposomes and 100 g ointment to obtain a compound ointment for diabetic wound healing.

[0043] Comparative Example 1

[0044] A compound ointment for diabetic wound healing and a preparation method thereof, comprising the following steps:

[0045] 1. Preparation of Ba33112 anionic micelles: 43 mg of sodium lignin sulfonate with a weight average molecular weight of 70,000 and 14 mg of Ba33112 were added to 4.7 ml of water, stirred thoroughly, dialyzed at a molecular weight cutoff of 13,000 Da, and the retentate was freeze-dried to obtain Ba33112 anionic micelles;

[0046] 2. Preparation of collagen hydrolyzate liposomes: 112 mg of egg yolk lecithin and 23 mg of cholesterol were dissolved in chloroform, and then the organic reagent was removed by rotary evaporation. After a uniform lipid film was formed on the bottom and inner wall of the ground glass tube, 22 ml of 9.8 g / L hydrolyzed collagen solution was added and vortexed at 56 ° C for hydration, and then extruded using a liposome extruder with a pore size of 270 nm, and freeze-dried to obtain collagen hydrolyzate liposomes;

[0047] 3. Mix 0.6 g of SOD with a specific activity of 11360 U / g, 0.5 g of Ba33112 anionic micelles, and 0.9 g of collagen hydrolyzate liposomes with 100 g of ointment to obtain a compound ointment for diabetic wound healing.

[0048] Comparative Example 2

[0049] A compound ointment for diabetic wound healing and a preparation method thereof, comprising the following steps:

[0050] 1. Preparation of SOD cationic micelles: 195 mg of polyquaternium-22 with a weight average molecular weight of 6500 and 20 mg of SOD with a specific activity of 11360 U / g were dissolved in 18 ml of water, stirred thoroughly, dialyzed with a molecular weight cutoff of 12500 Da, and the retentate was freeze-dried to obtain SOD cationic micelles;

[0051] 2. Preparation of collagen hydrolyzate liposomes: 112 mg of egg yolk lecithin and 23 mg of cholesterol were dissolved in chloroform, and then the organic reagent was removed by rotary evaporation. After a uniform lipid film was formed on the bottom and inner wall of the ground glass tube, 22 ml of 9.8 g / L hydrolyzed collagen solution was added and vortexed at 56 ° C for hydration, and then extruded using a liposome extruder with a pore size of 270 nm, and freeze-dried to obtain collagen hydrolyzate liposomes;

[0052] 3. Mix 0.6g SOD cationic micelles, 0.5g Ba33112, 0.9g collagen hydrolyzate liposomes and 100g ointment to obtain a compound ointment for diabetic wound healing.

[0053] Comparative Example 3

[0054] A compound ointment for diabetic wound healing and a preparation method thereof, comprising the following steps:

[0055] 1. Preparation of SOD cationic micelles: 195 mg of polyquaternium-22 with a weight average molecular weight of 6500 and 20 mg of SOD with a specific activity of 11360 U / g were dissolved in 18 ml of water, stirred thoroughly, dialyzed with a molecular weight cutoff of 12500 Da, and the retentate was freeze-dried to obtain SOD cationic micelles;

[0056] 2. Preparation of Ba33112 anionic micelles: 43 mg of sodium lignin sulfonate with a weight average molecular weight of 70,000 and 14 mg of Ba33112 were added to 4.7 ml of water, stirred thoroughly, dialyzed at a molecular weight cutoff of 13,000 Da, and the retentate was freeze-dried to obtain Ba33112 anionic micelles;

[0057] 3. Mix 0.6g SOD cationic micelles, 0.5g Ba33112 anionic micelles, 0.9g hydrolyzed collagen and 100g ointment to obtain a compound ointment for diabetic wound healing.

[0058] Infection Diabetes Wound Healing Experiment

[0059] Eight-week-old male SD rats were selected and fed with a high-fat and high-sugar diet for 4 weeks. They were given a single intraperitoneal injection of streptozotocin at 35 mg / kg to induce type 2 diabetes. They were randomly divided into 6 groups according to their body weight using a random number table method, with 5 rats in each group. After anesthesia, the left and right sides of their backs were depilated, and after disinfection with iodine, a circular wound with a diameter of about 1 cm was cut with a punch. 1×10 8 The wound was infused with the culture solution of Staphylococcus aureus at a concentration of 100 cfu / ml. After 1 day, the wound was treated with the ointments prepared in Examples 1-3 and Comparative Examples 1-3, respectively. The wound was then wrapped and fixed with medical gauze. The wound area was recorded and the wound area rate (the percentage of the wound area to the original wound area) was calculated. The results are shown in FIG. Figure 1 The same method and treatment were used. The animals were killed 4 days after the ointment treatment. The wound tissue was taken to determine the lipid peroxidation level using the MDA assay kit, and the expression of HIF-1α was determined by Western blot (with β-actin as an internal reference). The ratio of the gray value of HIF-1α to β-actin was plotted. The results are shown in Figure 2 .Depend on Figure 1 It can be seen that the ointment treatment of Examples 1-3 can shorten the healing time of diabetic wounds and is controlled within one week. Figure 2It also shows that the treatment of Examples 1-3 controlled the level of lipid peroxidation and upregulated the expression of HIF-1α. The ointments of Comparative Examples 1-3 had a longer healing time, reaching more than 3 weeks, especially the wounds treated with Comparative Examples 1 and 2 had not yet shown obvious signs of healing. The main reason is that Comparative Example 1 did not encapsulate SOD in cationic micelles, so that Fe(II) in the wound environment and the active atom Mn(II) in SOD produced competitive inhibition, resulting in SOD unable to catalyze normally, free radical accumulation, aggravated lipid peroxidation, and downregulation of HIF-1α ( Figure 2 ), and it is unable to produce H2O2 and O2, so it cannot effectively fight bacteria and improve wound oxygenation, hindering wound healing; in the treatment of comparative example 2, Ba33112 was not encapsulated by anionic micelles. Ba33112 itself is a reducing agent and can be inactivated by free radicals in tissue fluid, unable to upregulate HIF-1α, unable to chelate Fe(II), and SOD catalyzes H2O2 and O2 to react with it in a Fenton reaction, resulting in excessive ROS, downregulation of HIF-1α, and aggravated lipid peroxidation, causing ferroptosis ( Figure 2 ). The free hydrolyzed collagen in Comparative Example 3 may aggravate the infection of microorganisms and cause the wound to deteriorate. Under excessive oxidative stress and hypoxia, the combined regulation capacity of SOD cationic micelles and Ba33112 anionic micelles has been exceeded. Although the combination of SOD cationic micelles and Ba33112 anionic micelles can improve the molecular mechanism of the wound site, it is obviously inferior to the wound healing effect of Examples 1-3.

[0060] The present invention provides a compound ointment for diabetic wound healing and a method for preparing the same. There are many methods and approaches to implement the technical solution. The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be considered as the scope of protection of the present invention. All components not specified in this embodiment can be implemented by existing technologies.

Claims

1. A method for preparing a compound ointment for diabetic wound healing, characterized in that: The steps include: S1: Preparation of SOD cationic micelles: dissolve the quaternary ammonium polymer surfactant and SOD in water, stir thoroughly, dialyze, and freeze-dry the retentate to obtain SOD cationic micelles; wherein the dosage ratio of the quaternary ammonium polymer surfactant, SOD, and water is (150-230) mg: (15-23) mg: (15-22) mL; S2: Preparation of Ba33112 anionic micelles: sulfonate polymer surfactant and Ba33112 were added to water, fully stirred, dialyzed, and the retentate was freeze-dried to obtain Ba33112 anionic micelles; wherein the amount ratio of sulfonate polymer surfactant, Ba33112 and water was (39-50) mg: (5-18) mg: (4-5) mL; S3: Preparation of collagen hydrolysate liposomes: egg yolk lecithin and cholesterol are dissolved in chloroform, and then the organic reagent is removed by rotary evaporation. After a uniform lipid film is formed on the bottom and inner wall of the ground glass tube, the hydrolyzed collagen solution is added and vortexed to hydrate, and then extruded by a liposome extruder and freeze-dried to obtain collagen hydrolyzate liposomes; wherein the amount ratio of egg yolk lecithin, cholesterol and hydrolyzed collagen solution is (100-120) mg:(20-25) mg:(20-25) mL; S4: The SOD cationic micelles, Ba33112 anionic micelles, collagen hydrolyzate liposomes and the ointment are mixed to obtain a compound ointment for diabetic wound healing.

2. The preparation method according to claim 1, characterized in that: In step S1, the quaternary ammonium polymer surfactant is one of polyquaternium-37, polyquaternium-22 and polyquaternium-11.

3. The preparation method according to claim 1, characterized in that: In step S1, the weight average molecular weight of the quaternary ammonium salt polymer surfactant is 5000-8400, and the specific activity of SOD is 10000-12000 U / g.

4. The preparation method according to claim 1, characterized in that: In step S2, the sulfonate polymer surfactant is sodium lignin sulfonate or sodium polystyrene sulfonate.

5. The preparation method according to claim 1, characterized in that: In step S2, the weight average molecular weight of the sulfonate polymer surfactant is 50,000-80,000.

6. The preparation method according to claim 1, characterized in that: In steps S1 and S2, the molecular weight cut-off of the dialysis is 10000-14000Da.

7. The preparation method according to claim 1, characterized in that: In step S3, the concentration of the hydrolyzed collagen solution is 5-12 g / L, the hydration temperature is 55-60° C., and the pore size of the extrusion membrane is 200-400 nm.

8. The preparation method according to claim 1, characterized in that: In step S4, the dosage ratio of SOD cationic micelles, Ba33112 anionic micelles, collagen hydrolyzate liposomes and ointment is: (0.2-0.8) g: (0.3-0.8) g: (0.5-1.0) g: 100 g.

9. A compound ointment for diabetic wound healing prepared according to the method described in any one of claims 1 to 8.